Frailty Syndrome

Frailty is a geriatric syndrome of decreased physiological reserve across multiple organ systems that increases vulnerability to stressors, predicting adverse outcomes such as falls, hospitalization, disability, and mortality ^{[1]B2b[2]B2b[5]B2b}. It is distinct from normal ageing, disability, and multimorbidity, although these frequently coexist. Also called frailty syndrome, frailty in older adults , or simply frailty; the term pre-frailty describes an intermediate, potentially reversible stage.

Diagnostic Constructs

Two principal conceptual models guide classification:

• Fried Phenotype (FP): Frailty is present when three or more of five criteria, unintentional weight loss , exhaustion, weakness (low grip strength), slow gait speed, and low physical activity, are met ^{[1]B2b[2]B2b[4]B2a[11]B2b}. One or two criteria define pre-frailty; zero, robust.
• Frailty Index (FI): A deficit-accumulation model counting the proportion of age-related health deficits (symptoms, signs, diseases, disabilities) present in an individual ^[6]B3b[10]C4. Scores >0.25 typically denote frailty.

Additional validated tools include the Clinical Frailty Scale (CFS) (7-point subjective assessment), the FRAIL Scale, the Study of Osteoporotic Fractures (SOF) Index, and the Zulfiqar Frailty Scale (ZFS) ^{[8]B2b[9]C4[10]C4}. The Hospital Frailty Risk Score (HFRS) is widely used but lacks conceptual grounding in physiological reserve and is not recommended for individual risk stratification ^[3]B2a.

The prevalence of frailty varies markedly by instrument, from 26.8% (FRAIL Scale) to 62.9% (Frailty Index) in one hospitalized cohort ^[10]C4. This variability underscores that no single tool is universally accepted; the choice depends on setting and purpose.

Clinical Significance

Frailty is present in 10-15% of community-dwelling adults aged ≥65 years and increases steeply with age ^[4]B2a. It is an independent predictor of mortality, prolonged length of stay, nonroutine discharge, and institutionalisation, surpassing chronological age alone ^{[2]B2b[3]B2a[5]B2b[10]C4}. Identifying frailty early offers a window for intervention because the syndrome is potentially reversible, a central rationale for routine screening in older adults.

Controversies and Guideline Disagreement

There is no international consensus on the optimal diagnostic criteria. European and North American geriatric societies endorse both the Fried Phenotype and the Frailty Index, but pragmatic scales (CFS, FRAIL) are more feasible in acute care ^[10]C4. The HFRS, despite its popularity in surgical databases, has been explicitly advised against for individual patient assessment due to its lack of face validity ^[3]B2a. Future harmonisation efforts may integrate biomarker data such as APOE ε4 carrier status and vitamin D insufficiency, which show sex-specific associations with frailty ^{[1]B2b[11]B2b}.

Pearl: Frailty is a potentially reversible condition; early identification using validated screening is critical to prevent adverse outcomes.

The transition from robust aging to frailty reflects a critical breakdown in the integrated regulation of multiple physiological systems, shifting from homeostatic symphony to cacophony ^[15]D5. Two complementary models, the frailty phenotype and the frailty index, both converge on a common biological substrate: age-related dysregulation across inflammatory, oxidative, metabolic, and cellular repair pathways that, once crossing a threshold of severity, renders the organism unable to mount an adequate stress response ^[14]D5[15]D5.

Inflammaging as the Central Driver

Chronic low-grade systemic inflammation, termed inflammaging, is the most consistently implicated pathophysiological process in frailty ^[14]D5[17]D5. Elevated circulating levels of interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) are hallmark findings, and these cytokines directly impair muscle protein synthesis, reduce appetite, and promote catabolism ^[14]D5[22]C4. The NLRP3 inflammasome appears to be a key upstream activator: its upregulation triggers IL-1β production, which in turn suppresses erythropoiesis by increasing hepcidin and inducing relative iron deficiency ^{[19]B3b[20]C4}. Among community-dwelling older women, a higher ratio of anti-inflammatory IL-10 to pro-inflammatory IL-6 distinguished eutrophic from overweight frail individuals, suggesting that loss of anti-inflammatory counter-regulation is a core feature ^[22]C4. In the frail group from the InCHIANTI study, low plasma levels of the antioxidant vitamin E were independently associated with frailty (OR 0.30 for highest vs lowest tertile, 95% ^[12]B2b), linking oxidative stress directly to the inflammatory milieu.

Mitochondrial Dysfunction and Oxidative Stress

Mitochondrial dysfunction has emerged as a proximate mechanism driving both inflammaging and cellular senescence ^[13]D5[17]D5. Plasma from frail individuals induces functional impairment and nuclear DNA damage in allogeneic renal stem/progenitor cells, accompanied by mitochondrial respiratory failure and increased reactive oxygen species ^[24]B3b. The FRAMITO protocol is prospectively validating mitochondrial DNA damage and cellular bioenergetic deficits as frailty biomarkers, independent of multimorbidity ^[13]D5. Immune senescence in conditions such as multiple myeloma further accelerates this process through acquired mitochondrial abnormalities that compromise effector T-cell metabolism ^[17]D5.

Stem Cell Exhaustion and Impaired Tissue Repair

Frailty is associated with concurrent exhaustion of multiple stem cell compartments. Circulating hematopoietic progenitor cells from frail individuals show increased DNA damage compared to non-frail controls, and the same plasma triggers oxidative stress-mediated nuclear damage in renal stem/progenitor cells in vitro ^[24]B3b. This systemic stem cell compromise likely explains the failure to repair skeletal muscle micro-injuries, contributing to sarcopenia, the major component of the frailty phenotype ^{[23]D5[24]B3b}.

Epigenetic Modifications

Epigenetic regulators show altered expression in frailty and sarcopenia. In older adults, mRNA levels of DNA methyltransferase DNMT3A and sirtuin SIRT3 are upregulated compared to young controls, while FOXO3A, a transcription factor linked to longevity and antioxidant defense, is significantly lower in sarcopenic patients (p<0.001) ^[18]C4. FOXO3A downregulation may impair the cellular response to oxidative stress and accelerate muscle loss ^[18]C4.

Gut Microbiota Dysbiosis and Tryptophan Metabolism

Age-related changes in gut microbiota composition promote intestinal barrier dysfunction, allowing bacterial products to enter the circulation and fuel systemic inflammation ^[16]D5. Perturbations in tryptophan metabolism, particularly shunting toward the kynurenine pathway, generate metabolites that suppress T-cell function and promote muscle catabolism, linking dysbiosis to both sarcopenia and frailty ^[23]D5.

Together, these interconnected pathways, inflammaging, mitochondrial dysfunction, stem cell exhaustion, epigenetic drift, and gut dysbiosis, form a self-reinforcing system that, once past a critical threshold, drives the clinical syndrome of frailty. As described in Section 3, the presence of multi-morbidity and specific risk factors compounds these mechanisms, accelerating the trajectory toward disability.

Pearl: Frailty is not simply accelerated aging; it represents a state in which dysregulation across five or more physiological systems exceeds a critical threshold, making single-target interventions unlikely to succeed and explaining why multimodal strategies, especially exercise, remain the most effective treatment.

[Compilation failed for this section after 3 attempts. Manual review required.]

Frailty does not announce itself with a single symptom; it emerges insidiously, often first noticed by a family member who observes that the older adult is "slowing down" or "not getting around like they used to." The clinical picture is one of declining physiologic reserve across multiple systems, and the presentation is characteristically non-specific, a fall, an episode of confusion, or simply "failure to thrive" may be the initial clue.

Presenting Symptoms

Weakness is the most common first manifestation of frailty. In the Women's Health and Aging Study II, weakness (measured by grip strength) preceded other criteria in 76% of women who eventually became frail ^[30]B2b. Patients describe difficulty rising from a chair, carrying groceries, or opening jars. Slowness follows, perceived as a change in walking speed or needing more time to complete routine tasks. Self-reported exhaustion, feeling that "everything is an effort", and reduced physical activity often appear later, along with unintentional weight loss ^[30]B2b. Importantly, the order of symptom onset matters: women whose initial presentation included exhaustion or weight loss were 3 to 5 times more likely to progress to frailty than those without any criterion (p<0.05) ^[30]B2b. These symptoms should prompt urgent evaluation and intervention.

Depressive symptoms are tightly interwoven with frailty. In a cohort of older kidney transplant recipients, each additional point on the Geriatric Depression Scale increased the odds of being pre-frail by 39% (OR 1.39) and roughly doubled the odds of being frail (OR 2.01) ^[48]C4. Among frail middle-aged and older adults, depressive symptoms independently predicted adverse cognitive trajectories, with the strongest association seen for rapid cognitive decline (fully adjusted OR 3.10) ^[45]B2b. Clinicians should screen for depression in any patient presenting with frailty features.

Physical Examination Findings

The examination focuses on objective measures of the five Fried phenotype components. Grip strength is assessed with a hand dynamometer; cutoffs vary by sex and BMI, but weakness is typically defined as grip strength in the lowest 20% of the population. Gait speed over 4 or 6 meters is the most reproducible measure of slowness; a speed <0.8 m/s is a widely used threshold. Low physical activity is quantified using standardized questionnaires (e.g., Minnesota Leisure Time Activities). Exhaustion is elicited by asking how often in the past week the patient felt that everything was an effort or could not get going. Unintentional weight loss of ≥5% in the prior year is documented from records or serial weights. These five findings, when three or more are present, define the frailty phenotype.

Atypical Presentations

Frailty may present as recurrent falls, delirium during a minor illness, or prolonged recovery after a seemingly routine procedure. In a cohort of patients with anti-HMGCR myopathy, a condition that mimics frailty, 24% presented with falls and 2.7% with "general decline" ^[47]C4. The overlap between frailty and myopathy underscores the need to consider reversible causes when weakness is the dominant feature. Similarly, an older adult who becomes functionally dependent after a urinary tract infection or who fails to regain baseline mobility after hospitalization may be manifesting underlying frailty.

Red Flags

Rapid progression over weeks, new focal neurological signs, or a creatine kinase >1000 U/L should prompt investigation for an alternative diagnosis such as myositis or malignancy ^[47]C4. Acute illness superimposed on frailty often precipitates a cascade of functional decline, hospitalization, and institutionalization; early recognition and aggressive support are critical.

Pearl: Weakness is the most common first manifestation of frailty; when exhaustion or weight loss appear, the risk of rapid progression to frailty increases 3-5 fold ^[30]B2b.

The clinical presentation of frailty rarely occurs in isolation; it is embedded within a network of interrelated geriatric syndromes that share common risk factors and mutually reinforce one another. An acute stressor, infection, surgery, medication change, can trigger a cascade: a fall leads to immobility, which precipitates delirium, which worsens incontinence, which increases pressure injury risk, and the entire sequence accelerates functional decline. Understanding this cascade is essential for early recognition and interruption.

Falls and Gait Instability

Falls are the most visible sentinel event in frail older adults. Gait speed <0.8 m/s and the inability to rise from a chair without using arms are bedside markers that predict fall risk. The Otago Exercise Program, a home-based strength and balance intervention, significantly improves balance (weighted mean difference [WMD] 0.15, 95% CI -0.05 to 0.35), gait (WMD 0.49, 95% CI 0.18-0.80), and lower limb strength (WMD 0.84, 95% CI 0.61-1.07) in general older adults, with even greater effects in those with compromised health, including frailty ^[55]A1a. Mind-body training (e.g., Taiji, Baduanjin) is the most effective physical activity modality for reducing frailty (SMD -0.71, 95% CI -1.22 to -0.21) and improving quality of life (SMD 1.02, 95% CI 0.89-1.15), with optimal dosing of 50-60 minutes per session, 2-3 times weekly ^[42]A1a. Prehabilitation programs for (pre-)frail surgical patients reduce postoperative deterioration in care dependency (ICER €27,197 per prevented deterioration, 69% probability of cost-effectiveness at €50,000 willingness-to-pay) ^[50]A1b, but participation is hindered by gaps in knowledge, limited physical function, and inflexible attitudes ^[52]D5.

Delirium

Delirium is the acute confusional state that most dramatically signals vulnerability. In acute-care wards, frailty (Clinical Frailty Scale >4) is one of three factors, alongside age >85 years and presence of invasive devices, that together explain 95% of delirium cases ^[37]C4. Dementia, other psychiatric illness, chronic antipsychotic treatment, and invasive devices maximize individual-level risk, with coexistence of three factors producing a peak delirium frequency of 57-61%, predominantly hypoactive forms ^[37]C4. Directed acyclic graphs from the SNAP-3 study clarify that frailty, multimorbidity, and delirium share causal pathways involving age, dementia, polypharmacy, and operative severity, making statistical adjustment for these confounders essential in research ^[32]D5.

Urinary Incontinence

Urinary incontinence is both a consequence and a contributor to the cascade. Immobility after a fall or delirium prevents timely toileting, leading to functional incontinence. Conversely, chronic incontinence increases caregiver burden and social isolation, accelerating frailty progression. Although specific trial data in frail populations are limited, the association between frailty and incontinence is well established: in the Women's Health and Aging Studies, frail women had significantly lower serum carotenoids, vitamin D, vitamin B6, and folate, and those with ≥2 micronutrient deficiencies had higher odds of frailty (p=0.05) ^[53]C4. Nutritional optimization may indirectly improve pelvic floor function.

Immobility

Weakness is the most common first manifestation of frailty, preceding slowness and low physical activity in 76% of women who transition from non-frail to frail ^[30]B2b. Once immobility sets in, it begets further deconditioning. Pain and disability are potent drivers: older women with low back pain and greater disability have 2.83 times higher odds of transitioning to worse frailty levels over 6-12 months ^[36]B2b. Chair rise ability (the ability to stand from a chair without arms) is associated with reduced mortality after percutaneous coronary intervention (HR 0.32, 95% CI 0.11-0.92) ^[57]B2b, underscoring its prognostic value.

Pressure Injury

Prolonged immobility, combined with malnutrition and reduced tissue perfusion, creates the perfect environment for pressure injury. In frail older adults with chronic wounds, a pharmaco-mechanical synergy protocol for blind nasoenteric tube insertion achieved a 76.2% success rate and significantly improved serum total protein and albumin (p<0.05) without insertion-related complications ^[56]C4. This highlights that nutritional repletion is feasible even in the most vulnerable patients and may support wound healing.

Syndrome Clustering and the Cascade

These syndromes do not occur independently. Frailty and cognitive impairment are tightly linked: prefrail and frail individuals perform worse across multiple cognitive domains (global cognition, memory, executive function) compared with robust peers, even after full adjustment ^[59]C4. Chronic stress, as seen in Alzheimer caregivers, accelerates biological aging: caregivers have higher interleukin-6 (1.38 vs 1.00 pg/mL) and D-dimer (723 vs 471 ng/mL, p<0.001), suggesting a more rapid transition to frailty ^[54]C4. Genetic factors also contribute: APOE ε4 carriers have 2.75 times higher odds of frailty ^[1]B2b, and the CNTF null allele is associated with 3.80 kg lower grip strength ^[49]C4.

Recognition of this cascade at the bedside, a frail patient who falls, becomes delirious, cannot toilet, and develops a pressure ulcer, prompts a systematic diagnostic workup that addresses each contributing domain (see Section 6).

Pearl: When a frail older adult presents with one geriatric syndrome (e.g., a fall), actively screen for the others, delirium, incontinence, immobility, and pressure injury, because the cascade is already underway and early interruption preserves independence.

The cascade from frailty to disability is not inevitable, but its trajectory depends on early, systematic identification. The gold-standard diagnostic test for frailty syndrome is the Comprehensive Geriatric Assessment (CGA), a multidisciplinary evaluation that integrates medical, functional, cognitive, and psychosocial domains ^[61]B2a. CGA is resource-intensive, requiring a trained geriatrician and allied health team, so in practice the diagnosis proceeds through tiered steps: screening, confirmation with a validated operational definition, and CGA for management planning.

Screening Instruments

Bedside screening should precede formal diagnosis. The Clinical Frailty Scale (CFS) is the most practical first step: a judgment-based 9-point scale that takes <5 minutes. A score >4 (vulnerable or frail) identifies patients requiring further evaluation. In acute-care settings, the combination of age >85 years, CFS >4, and presence of invasive devices explained 95% of delirium cases among older inpatients, making the CFS a powerful risk-stratification tool even before full workup ^[37]C4. Other valid screens include the FRAIL scale and the simple question "Do you feel exhausted?" (from the Fried phenotype).

Gold-Standard Confirmation: The Fried Phenotype and Frailty Index

Two operational definitions anchor the diagnosis.

The Fried Phenotype (also called the Cardiovascular Health Study criteria) requires at least 3 of 5 components to be present:

• Unintentional weight loss (≥5% in prior year)
• Self-reported exhaustion (two questions from the CES-D)
• Weakness (grip strength in the lowest 20%, adjusted for sex and BMI)
• Slow walking speed (usual gait speed <0.8 m/s)
• Low physical activity (kcal/week in the lowest quintile). Individuals with 1-2 criteria are classified as pre-frail, a stage that is potentially reversible ^[63]B2b. The phenotype has been validated across populations, including community-dwelling adults aged 50 and older in whom weakness and slow gait showed the strongest independent associations with cognitive decline ^[59]C4.

The Frailty Index (FI) is an alternative, counting accumulated deficits (symptoms, signs, disabilities, diseases) as a proportion of ≥30 items. An FI ≥0.25 defines frailty ^[65]C4. The FI captures a broader spectrum of vulnerability than the phenotype and is more sensitive to subtle changes over time, but it is less practical for busy clinical settings.

The Role of the Comprehensive Geriatric Assessment (CGA)

Once frailty is identified by phenotype or FI, CGA remains the definitive workup because it reveals the underlying drivers and guides a tailored plan. CGA systematically evaluates:

• Medical: multimorbidity, polypharmacy, nutrition, sensory deficits
• Functional: activities of daily living (ADLs), instrumental ADLs, mobility (e.g., Timed Up and Go test, 6-minute walk test)
• Cognitive: Mini-Mental State Examination, Montreal Cognitive Assessment ^[59]C4
• Psychosocial: mood, social support, caregiver burden.

While CGA is the gold standard, resource constraints have spurred interest in proxy markers. A composite radiological score (including sarcopenia, osteoporosis, abdominal aortic calcification) achieved an AUROC of 0.686 for detecting moderate-to-severe frailty, indicating promise but not yet ready for stand-alone use ^[64]C4. Inflammatory biomarkers (IL-6, hs-CRP, IL-10) are significantly elevated in frail individuals, with stronger associations in women than men ^[65]C4, and micronucleus frequency in lymphocytes has been proposed as a complementary tool ^[66]C4. None, however, replaces clinical judgment anchored in CGA.

Diagnostic Algorithm

Step 1: Screen, Administer the CFS or FRAIL scale in any patient ≥70 years (or ≥65 with significant comorbidity). Step 2: Confirm, If CFS >4 or FRAIL score ≥3, assess the Fried phenotype (or compute an FI if data available). A score ≥3 (Fried) or FI ≥0.25 confirms frailty. Step 3: Evaluate, Refer for CGA to delineate the specific deficits (strength, gait, cognition, nutrition, polypharmacy) and to guide multidisciplinary intervention ^[58]C4. Step 4: Stratify, Use frailty stage (pre-frail vs. frail) and CFS score for risk stratification and to trigger preventive measures (e.g., prehabilitation before elective surgery ^[50]A1b, early delirium precautions ^[37]C4).

Pearl: A Clinical Frailty Scale score >4 combined with age >85 years captures most older adults who will develop delirium during hospitalization, a 5-second screen that directs further workup and protective interventions ^[37]C4.

Once the Comprehensive Geriatric Assessment has confirmed frailty, the next step is to grade its severity and forecast risk, a process that directly determines the intensity and targets of intervention. Frailty is not binary; it spans a continuum from robustness through prefrailty to advanced frailty, with each stratum carrying distinct prognostic implications.

Operationalizing Severity: The Two Dominant Frameworks

Two validated systems dominate clinical staging. The Fried phenotype scores 0-5 using weight loss, exhaustion, low activity, slow gait, and weak grip: 0 = robust, 1-2 = prefrail, ≥3 = frail. The Rockwood Frailty Index (FI) quantifies accumulated deficits (e.g., comorbidities, disabilities) as a ratio of 0 to 1; an FI > 0.25 is conventionally frail. The Clinical Frailty Scale (CFS) collapses these into a 9-point descriptive hierarchy (1 = very fit, 9 = terminally ill) for rapid bedside use. Fried is optimal for research and outpatient screening, FI for CGA-based quantification, and CFS for multidisciplinary communication.

The Prognostic Gradient of Frailty Severity

Each step upward in severity magnifies adverse outcome risk. Pre-stroke frailty (pooled prevalence 24.6%, 95%%) carried an OR 3.75 for longer-term mortality ^[25]B2a. In hemodialysis patients, frailty conferred a 3-5-fold higher mortality compared with non-frail status ^[39]B2b. Among older adults with pneumonia, median survival was 62 days (vs 274 days) when frailty-driven aspiration was present, though frailty itself, not the aspiration label, drove the association ^[5]B2b.

Prefrailty is a critical intermediate state. Over two years, 32.9% of community-dwelling older adults transitioned to prefrailty and 1.7% to frank frailty ^[34]B2b. In hemodialysis, prefrail individuals had markedly lower mortality than frail ones ^[39]B2b. Stratification into these three tiers thus identifies a window for preventive intervention.

Biological Risk Modifiers Beyond Phenotype

Genetic, nutritional, and physical performance markers further refine risk. The APOE ε4 allele increased the odds of frailty by 2.75-fold in fully adjusted models), independent of dementia ^[1]B2b. Nutritional threats are powerful: severe anorexia (AOR 4.17), moderate anorexia (AOR 2.31), and BMI < 19 (AOR 4.11) were the strongest longitudinal predictors of incident prefrailty or frailty ^[34]B2b. Conversely, maintaining total dietary iron intake (OR 0.47, 95% CI 0.24-0.93) and increasing non-heme iron intake (OR 0.41, 95% CI 0.20-0.88) significantly reduced incident frailty ^[70]B2b.

Physical fitness components correlate robustly with frailty severity, with usual walking speed showing the strongest association, followed by aerobic capacity, maximum walking speed, lower body strength, and grip strength ^[67]B2a. Muscle strength and balance also mediate the link between frailty and osteoporosis ^[68]C4. Low plasma hippuric acid, a gut microbiota-derived metabolite linked to fruit-vegetable intake, appears as a hallmark of frailty ^[69]C4.

Clinical Application: Stratification-Guided Intensity

The severity grade directs management intensity. Robust individuals need primary prevention (exercise, nutrition, health maintenance). Prefrail patients are prime candidates for targeted physical activity programs, the LIFE-P trial showed that a 12-month exercise intervention reduced frailty prevalence from 19.1% to 10.0% ^[27]A1b, along with nutritional optimization and weight monitoring. Frail patients require comprehensive geriatric assessment, prehabilitation before elective surgery ^[43]B2b, polypharmacy review (covered in Section 10), and integrated multidisciplinary care to slow progression and prevent hospital-associated harm.

Severity stratification also informs prognosis in post-procedural settings. In patients undergoing PCI, frailty itself was not independently associated with the composite endpoint of death or readmission, but the unintended weight loss component of the SOF index was a significant predictor of readmission (adjHR 1.20, 95%), while preserved chair rise ability predicted lower mortality (HR 0.32) ^[57]B2b.

Pearl: The prefrail stratum is the most actionable, it is both high-risk for progression (32.9% over 2 years) and responsive to simple lifestyle interventions (exercise, nutrition) that can bend the trajectory back toward robustness. Screen aggressively in this group.

This severity stratification sets the stage for acute care considerations, as frailty increases susceptibility to hospital-associated harm, detailed in the next section.

Frailty staging directly influences acute care, patients with Clinical Frailty Scale (CFS) >4 or age >85 years are at highest risk for hospital-acquired delirium and other adverse outcomes ^[37]C4. In acute wards, the presence of any one of these three factors, age >85, CFS >4, or use of invasive devices, explains 95% of delirium cases ^[37]C4. This finding makes preemptive bundle deployment a logical next step after risk stratification.

Prevention of Delirium

Dementia, other psychiatric illness, chronic antipsychotic use, and invasive devices are individual-level risk factors that maximize delirium incidence, with the coexistence of three factors producing a peak delirium frequency of 57-61%, mostly hypoactive forms ^[37]C4. The strongest individual risks are dementia and antipsychotic use, which are often modifiable at admission. Non-pharmacological prevention bundles, early mobilization, orientation protocols, sleep hygiene, minimizing invasive devices, and deprescribing anticholinergic medications, should be deployed for every patient meeting any one of the three sentinel criteria, not only after delirium develops.

Prevention of Functional Decline and Iatrogenic Harm

Hospitalization itself accelerates deconditioning in frail older adults. Frailty is independently associated with longer hospital stay (median 18 vs 15 days in ICU survivors ^[80]B2b) and higher rates of hospital-acquired infections (48.7% vs 20.9% ^[80]B2b). Early mobilization, maintaining nutrition, and avoiding unnecessary bed rest are essential to prevent pressure injury and further functional loss. Medication review on admission, targeting polypharmacy, which correlates strongly with frailty severity ^[74]C4, can prevent prescribing cascades (e.g., treating antipsychotic-induced hypotension with additional antihypertensives). Proactive skin assessment and repositioning schedules reduce pressure injury risk.

Perioperative Considerations

Among patients undergoing emergency abdominal surgery, frailty prevalence is 30.8% and all-cause mortality among frail patients is 24.7% (OR 4.3 vs non-frail) ^[73]B2a. Postoperative delirium occurs in 16.3% of emergency cases versus 2.7% elective ^[75]B2b. Despite 98.2% of surgeons agreeing frailty is important, only 1.2% use a specific frailty screening tool, and 2.4% perform comprehensive geriatric assessment (CGA) ^[76]C4. Routine frailty screening using CFS or the Study of Osteoporotic Fractures (SOF) criteria ^[71]B2b should be integrated into acute surgical assessment, paired with collaborative perioperative care models (e.g., POPS, Perioperative medicine for Older People undergoing Surgery) to target modifiable deficits before surgery ^{[73]B2a[76]C4}.

Vaccination in Frail Older Adults

COVID-19 vaccination was prioritized for long-term care residents despite their exclusion from initial RCTs, because observational data in this vulnerable population demonstrate protection against infection and death ^[77]D5. Frail older adults should receive all indicated vaccines (influenza, pneumococcal, COVID-19, herpes zoster ) without deferral based on frailty status. The immune response may be attenuated, but clinical effectiveness against severe outcomes is retained.

Patient Education

Patients and caregivers should be counseled that hospitalization poses specific risks for older adults with frailty, delirium, functional decline, and iatrogenic complications, and that early mobilization, medication reconciliation, and advance care planning are proactive measures to mitigate these harms. Encouraging family presence, orientation cues, and mobility assistance can substantially reduce the incidence of hospital-associated disability.

Pearl: In acute care, the combination of age >85 years, CFS >4, and invasive devices accounts for 95% of delirium, instituting non-pharmacological prevention bundles for all patients meeting any one criterion is a high-yield, low-cost intervention ^[37]C4.

Following the acute hospitalization and prevention of harm addressed in the previous section, the central task for the clinician is to reverse the frailty phenotype and maintain functional independence in community-dwelling and institutionalised patients alike. This requires a sustained, multimodal approach that directly targets the underlying deficits, muscle weakness, poor nutrition, cognitive decline, and reduced activity, rather than any single agent or isolated clinic visit.

Step 1: Multimodal Rehabilitation, Exercise, Nutrition, and Cognitive Training

Initiate a multicomponent exercise program as the foundation of long-term frailty management . Meta-analyses of 34 randomized trials demonstrate that rehabilitation programs combining moderate-intensity resistance, balance, and aerobic exercise with nutritional monitoring, cognitive training, and medical support improve performance in activities of daily living (SMD = 0.83; 95% CI, 0.26-1.40; low certainty), lower extremity function (SMD = 0.63; 95% CI, 0.40-0.86; moderate certainty), and gait speed (SMD = 1.07; 95% CI, 0.17-1.97; low certainty) ^[29]A1a. The same analysis found a significant reduction in frailty prevalence (RR = 0.76; 95% CI, 0.65-0.89) ^[29]A1a. A network meta-analysis of 35 RCTs (N = 2,905) ranks mind-body training (e.g., Taiji, Baduanjin) as the most effective modality for frailty reduction (SMD = -0.71; 95% CI, -1.22 to -0.21) and quality of life (SMD = 1.02; 95% CI, 0.89-1.15), while aerobic training best enhances ADL performance (SMD = 0.89; 95% CI, 0.06-1.72) ^[42]A1a. The optimal dose is 50 to 60 minutes per session, 2 to 3 times per week ^[42]A1a. For institutionalised older adults, multicomponent exercise programs achieve frailty reversal in 36% of participants, with benefits extending to individuals over 85 years ^[85]B2a.

Cognitive benefits are also substantial: a meta-analysis of 6 RCTs showed that physical exercise improves global cognition (mean difference = 2.26; 95% CI, 0.42-4.09) and mental flexibility on the Trail Making Test Part B (mean difference = -30.45; 95% CI, -47.72 to -13.19) ^[84]A1a.

*In the network meta-analysis ^[42]A1a, these modalities did not reach significance for that outcome relative to control.

Step 2: Individualised Nutritional Support

For malnourished frail patients, especially those hospitalized, protocol-guided nutritional support targeting specific protein and energy goals sharply reduces mortality. In a secondary analysis of the EFFORT trial including 881 patients with aging-related vulnerability (23.4% with frailty, 81.8% aged ≥80 years), individualized nutritional support compared with routine hospital food reduced 30-day mortality from 13.6% to 7.1% (OR = 0.48; 95% CI, 0.31-0.76; P = 0.002). NNT = 16 to prevent one death at 30 days ^[83]B2b. Improvements persisted at 180 days and were accompanied by better functional outcomes and quality of life ^[83]B2b. Therefore, any frail patient in hospital should undergo nutritional risk screening (e.g., Nutritional Risk Screening 2002 ≥ 3) and receive a tailored intervention; this principle extends to the community setting as part of comprehensive geriatric management.

Step 3: Prehabilitation Prior to Elective Surgery

Frail and pre-frail older adults scheduled for elective surgery benefit from a structured prehabilitation program (multicomponent exercise, nutrition, and psychosocial support). The PRAEP-GO trial showed that prehabilitation reduced the risk of functional deterioration at 12 months, with an incremental cost-effectiveness ratio of 27,197 EUR per patient with a deterioration in care dependency prevented (69% probability of being cost-effective at a €50,000 willingness-to-pay threshold) ^[50]A1b. Cost-utility improved further when patients completed at least 15 sessions in an outpatient setting ^[50]A1b. Prehabilitation should be offered to all pre-frail/frail surgical candidates whenever surgery can be delayed 4-6 weeks.

Step 4: Neuromuscular Electrical Stimulation as an Adjunctive Option

For frail patients who cannot participate in active exercise, for example, after acute myocardial infarction with percutaneous coronary intervention, neuromuscular electrical stimulation (NMES) offers a practical alternative. A single-blind RCT (N = 100) demonstrated that 30 minutes of daily NMES to bilateral quadriceps and gastrocnemius for 7 days postoperatively significantly reduced frailty scores and improved lower limb muscle strength compared with usual care (P < 0.001) ^[82]A1b. While not a long-term regimen, NMES can serve as a bridge during early recovery periods when volitional exercise is contraindicated.

What NOT to Do

No pharmacologic agent has been approved for the treatment of frailty syndrome. Testosterone, growth hormone, vitamin D alone, or anti-inflammatory drugs lack consistent evidence of benefit and may cause harm in this vulnerable population. Avoid prescribing a single intervention in isolation; the evidence consistently supports multimodal, tailored programs that address exercise, nutrition, cognitive stimulation, and psychosocial support together ^{[29]A1a[42]A1a[85]B2a}.

Controversies and Guideline Disagreement

Pearls

Pearl: Start multimodal rehabilitation (exercise 2-3 times/week + individualised nutrition) as soon as frailty is identified, reversal is achievable even in adults over 85 years, with a NNT = 16 for mortality reduction with nutritional support in hospitalized malnourished frail patients ^{[83]B2b[85]B2a}. Prehabilitation before elective surgery is cost-effective when adherence is ensured ^[50]A1b.

Long-term management of frailty must contend with the multimorbidity and polypharmacy that almost invariably accompany the syndrome. Over 90% of frail older adults have two or more chronic conditions, and the accumulation of diseases, rather than any single diagnosis, drives the vulnerability that defines frailty ^[92]B2b. In the TOPCAT trial of heart failure with preserved ejection fraction, 94% of participants met frailty criteria (Frailty Index >0.21), and greater frailty severity was associated with higher risks of cardiovascular outcomes and mortality, yet the benefit of spironolactone was not attenuated by frailty class ^[92]B2b. This finding underscores a core principle: frailty should not automatically preclude evidence-based pharmacotherapy, but it demands careful individualization.

Polypharmacy and Potentially Inappropriate Medications

Polypharmacy, commonly defined as the concurrent use of five or more medications, is present in 60- of frail older adults and is independently associated with adverse outcomes including falls, hospitalization, and mortality. The Beers Criteria and the EU(7)-PIM list identify medications that are potentially inappropriate in older adults, particularly those with frailty. In the COFRAIL cluster randomized trial, community-dwelling adults aged ≥70 with frailty and polypharmacy (mean 9 medications at baseline) were randomized to general practitioner-led family conferences for shared decision-making about deprescribing versus usual care ^[90]A1b. At 6 months, the intervention group had a significant reduction in mean number of medications (from 8.98 to 8.11 vs. 9.24 to 9.32 in controls; P=0.001) and in potentially inappropriate medications (EU^[7]C4-PIM: 1.30 vs. 1.71;). However, the primary outcome, hospitalizations within 12 months, did not differ between groups (adjusted mean 0.98 vs. 0.99) ^[90]A1b. This suggests that deprescribing can reduce medication burden but may not translate into reduced acute care utilization without concurrent attention to non-pharmacologic management.

Deprescribing Strategies

A structured deprescribing approach should be integrated into comprehensive geriatric assessment . Key steps include:

1. Medication reconciliation at every encounter, with explicit documentation of indication, dose, and duration.
2. Identification of potentially inappropriate medications using validated tools (Beers, STOPP/START, EU^[7]C4-PIM).
3. Shared decision-making involving the patient, family caregivers, and primary care provider. The COFRAIL model used three family conferences over 9 months, which also addressed non-pharmacologic alternatives (e.g., exercise, dietary advice) ^[90]A1b.
4. Tapering rather than abrupt discontinuation for medications with withdrawal risks (e.g., benzodiazepines, proton pump inhibitors, antihypertensives).
5. Monitoring for adverse withdrawal events and re-evaluating within 4-6 weeks.

Barriers to deprescribing include patient reluctance, perceived lack of alternatives, and time constraints in primary care. Nurse-led interventions have shown promise in improving physical function, nutritional status, and quality of life in frail older adults, though evidence remains limited ^[89]B2a.

Goals of Care

Frailty alters the risk-benefit calculus for many interventions. For example, prehabilitation before elective surgery in (pre-)frail patients may be cost-effective (ICER €45,547 per QALY gained) but requires careful patient selection and adherence ^[50]A1b. Qualitative data from the PRAEP-GO trial highlight that personalized advice, well-organized programs, and addressing gaps in knowledge facilitate participation, while limited physical function and inflexible attitudes are barriers ^[52]D5.

In advanced frailty, the focus shifts from disease-specific targets to maintaining function, independence, and quality of life. Deprescribing should be coupled with non-pharmacologic strategies (exercise, nutrition, social support) to avoid replacing one risk with another. The absence of a hospitalization benefit in COFRAIL ^[90]A1b does not negate the value of reducing pill burden and potentially inappropriate medications; rather, it emphasizes that deprescribing is one component of a broader, goal-concordant care plan.

Pearl: In frail older adults with polypharmacy, a structured deprescribing intervention (e.g., family conferences) can reduce the number of medications and potentially inappropriate prescriptions, though impact on hard outcomes like hospitalization remains unproven ^[90]A1b.

The evolution of treatment toward patient-centered goals has made managing multimorbidity and polypharmacy a central challenge in frailty care. Multimorbidity, the coexistence of two or more chronic conditions, is present in nearly two-thirds of older surgical patients (63.1% in the SNAP-3 cohort) and frequently overlaps with frailty ^{[75]B2b[96]B2b}. However, frailty and multimorbidity are distinct constructs: frailty independently predicts adverse outcomes beyond the effect of comorbidity count. In the SNAP-3 analysis, multimorbidity increased the odds of postoperative morbidity by 46% (adjusted OR 1.46), but had no significant impact on length of stay, delirium, or mortality once frailty was accounted for ^[96]B2b. The causal path from multimorbidity to poor outcomes is often mediated through frailty itself, making the latter the more actionable target for intervention ^[32]D5.

Polypharmacy: Prevalence, Risks, and Identification

Polypharmacy, conventionally defined as the daily use of ≥5 medications, afflicts the majority of older adults with frailty ^[90]A1b. Each additional drug increases the risk of adverse drug events, falls, delirium, and hospitalization, compounded by age-related changes in pharmacokinetics and pharmacodynamics. The COFRAIL cluster RCT enrolled community-dwelling adults aged ≥70 years with frailty and polypharmacy (mean 8.9 medications at baseline) ^[90]A1b. Potentially inappropriate medications (PIMs), identified using validated lists such as the Beers Criteria , the STOPP/START criteria, or the EU(7)-PIM list, are common in this population. In COFRAIL, the mean number of EU(7)-PIMs at baseline was 1.30 in the intervention group ^[90]A1b.

Deprescribing: Evidence and Implementation

Deprescribing, the supervised reduction or discontinuation of medications that are no longer beneficial or potentially harmful, is a core intervention for managing polypharmacy in frailty. The COFRAIL trial tested a structured approach: general practitioners received training on family conferences, a deprescribing guideline, and a toolkit of nonpharmacologic alternatives ^[90]A1b. In the per-protocol analysis, the mean number of medications decreased from 8.98 to 8.11 at 6 months in the intervention group versus 9.24 to 9.32 in the control group, and the number of EU(7)-PIMs fell significantly at 6 months (1.30 vs 1.71) ^[90]A1b. However, the effect on medication number was not sustained at 12 months, and there was no difference in hospitalizations (ITT mean 0.98 vs 0.99) ^[90]A1b.

Barriers to deprescribing in primary care are substantial. In a qualitative study of 30 Greek GPs, physicians cited lack of expertise, inadequate communication skills, time constraints, negative beliefs among patients and providers, and absence of a national polypharmacy initiative ^[98]C4. Facilitators included incorporation of deprescribing recommendations into guidelines, fostering a strong doctor-patient relationship, promoting shared decision-making , and leveraging nonpharmacological therapies ^[98]C4. Effective deprescribing thus requires a systematic, patient-centered approach: review all medications, identify PIMs using validated lists, weigh benefit versus harm in the context of the patient’s goals and life expectancy, engage the patient and caregiver, taper gradually (especially for beta-blockers, benzodiazepines, and psychotropics to avoid withdrawal syndromes), and monitor for changes in symptoms and function.

Nonpharmacological interventions, particularly structured physical activity , can offset the effects of deprescribing and improve frailty status. The LIFE-P trial demonstrated that a 12-month physical activity intervention reduced frailty prevalence from 1 to 10.0% at 12 months (absolute risk reduction; NNT = 11) ^[27]A1b. Regular exercise, along with nutritional optimization and cognitive training, forms the backbone of a comprehensive frailty management plan that complements medication reduction ^{[99]D5[67]B2a}.

Goals of Care and Shared Decision-Making

Deprescribing decisions must be anchored to the patient’s goals of care. For a frail older adult with limited life expectancy, preventive medications (e.g., statins , bisphosphonates) often provide little benefit relative to the burden of daily administration and risk of adverse effects. In the perioperative setting, comprehensive geriatric assessment and frailty assessment should guide shared decision-making about surgery, as frail patients face higher rates of morbidity and mortality ^{[95]B2a[94]B2a}. The SNAP-3 subgroup analysis found that frailty was most prevalent among patients undergoing hip fracture surgery (58.2%), those aged ≥85 years (49.3%), and those undergoing emergency procedures (31.4%), all of whom experienced markedly worse outcomes ^[75]B2b. Discussing these risks transparently with patients and families aligns care with individual preferences.

A multidisciplinary team, including a geriatrician, pharmacist, physiotherapist, and social worker, is essential for integrating deprescribing into a holistic care plan ^[99]D5. Telemedicine and wearable technologies can facilitate ongoing monitoring, particularly for patients in remote areas ^[97]D5.

Pearl: Deprescribing in frail older adults is most successful when embedded in a multidisciplinary care framework, guided by validated screening tools like Beers Criteria and STOPP/START , and coupled with nonpharmacological strategies such as structured physical activity and nutritional support; even a 6-month reduction in medication count (as seen in COFRAIL) may improve safety, but sustained benefit requires ongoing monitoring.

The trajectory that follows a diagnosis of frailty is not uniform, but patterns of progression, survival, and functional decline have been characterized in longitudinal cohorts.

Natural History of Progression

In the Women's Health and Aging Study II, the 7.5-year incidence of frailty among initially non-frail community-dwelling women aged 70-79 years was 9% ^[30]B2b. Weakness was the most common first manifestation, and the occurrence of weakness, slowness, and low physical activity preceded exhaustion and weight loss in 76% of women who became frail. Women presenting with exhaustion or weight loss as initial symptoms were 3-5 times more likely to progress to frailty than those without any criterion (p<0.05) ^[30]B2b. These findings suggest that weakness serves as an early warning sign, while weight loss and exhaustion mark a more accelerated trajectory.

Survival Outcomes

Pre-stroke frailty, measured by frailty index or Hospital Frailty Risk Score, is present in approximately of acute stroke patients and is associated with a 3.75-fold increase in longer-term mortality (OR 3.75) ^[25]B2a. In older adults hospitalized with pneumonia, frailty rather than the label of aspiration pneumonia drives prognosis: median survival was 62 days in those diagnosed with aspiration pneumonia versus 274 days in non-aspiration pneumonia, but after adjustment for frailty and comorbidities, aspiration diagnosis was not an independent predictor ^[5]B2b.

Functional Outcomes

Among frail older adults undergoing colorectal cancer surgery who completed a prehabilitation program, functional performance (6-minute walk test, Timed Up and Go) remained stable at one year despite a small but statistically significant increase in frailty as measured by the 5-item Frailty Index (mean difference 0.029, p=0.012) ^[43]B2b. This dissociation between physiological vulnerability and functional status suggests that targeted interventions may preserve function even as frailty progresses. Neuromuscular electrical stimulation applied to the lower limbs for 30 minutes daily for 7 days after percutaneous coronary intervention reduced frailty scores and improved lower limb strength compared to usual care (p<0.001) ^[82]A1b.

Competing Mortality and Prognostic Factors

Frailty acts as a competing risk for many outcomes. In the CONCARDPCI study, 18% of patients undergoing PCI were frail by the Study of Osteoporotic Fractures index; 45% of frail patients experienced the composite endpoint of 1-year mortality or readmission, compared to 33% of robust patients ^[57]B2b. Unintended weight loss was independently associated with readmission (adjHR 1.20, 95%), while ability to perform a chair rise was associated with reduced mortality (HR 0.32, 95% CI 0.11-0.92) ^[57]B2b.

Biomarkers may refine prognosis. Frail individuals have significantly higher frequencies of micronucleus in lymphocytes (19.16 vs 13.07 per 1000 cells, p<0.001) and binucleated buccal cells, indicating genomic instability ^[66]C4. Carriers of the APOE ε4 allele have 2.75-fold higher odds of frailty, independent of dementia status ^[1]B2b.

The natural history of frailty is one of progressive vulnerability, but the rate and pattern vary. Early identification of weakness and targeted interventions may alter the trajectory. The next section addresses special populations and end-of-life contexts where these prognostic considerations become paramount.

Pearl: In a frail older adult, the presence of unintended weight loss or exhaustion should trigger aggressive intervention, as these symptoms herald a 3-5 fold increased risk of rapid progression to frailty ^[30]B2b.

The prognostic trajectory of frailty is not uniform across populations; its expression and management differ sharply in the oldest-old, those with dementia or immunocompromise, and at the end of life.

Elderly (Oldest-Old, Long-Term Care, Dementia)

In patients aged ≥85 years or living in long-term care, frailty is nearly universal and often coexists with dementia and multimorbidity. Pre-stroke frailty prevalence is 24.6%, with any frailty syndrome reaching 66.8% among stroke patients ^[25]B2a. The combination of age >85 years, Clinical Frailty Scale (CFS) >4, and invasive devices explains 95% of delirium cases in acute care ^[37]C4. Cognitive function across multiple domains is significantly worse in prefrail and frail individuals aged ≥50, with weakness and slow gait most consistently linked to poorer cognition ^[59]C4. Management modifications include lowering treatment intensity thresholds, prehabilitation programs (≥15 sessions) can prevent deterioration in care dependency (ICER €27,197 per patient prevented) ^[50]A1b, and prioritizing fall prevention via the Otago Exercise Program, which improves gait (WMD 0.92, 95% CI 0.13-1.72) and lower limb strength (WMD 2.24, 95% CI 1.04-3.45) more in compromised health ^[55]A1a. Deprescribing and goal-concordant care replace aggressive intervention; blind nasoenteric tube insertion using a pharmaco-mechanical protocol is feasible (success rate 76.2%, no insertion-related complications) for frail older adults with chronic wounds needing nutritional support ^[56]C4.

Immunocompromised (HIV)

Older adults with HIV (HOAs) aged ≥50 develop frailty at a younger age due to chronic inflammation and central obesity. In one cohort, 60% met Fried frailty criteria despite a mean age of only 58 years and preserved CD4 counts (mean 569 cells/mL) ^[60]C4. Frail HOAs had greater impairments in Physical Performance Test, peak oxygen uptake, and gait speed compared with nonfrail HOAs, with body mass index and truncal fat ( lipodystrophy ) as key predictors (PPT score inversely related to trunk fat, r = -0.34) ^[60]C4. Management should integrate lifestyle interventions (exercise, diet) targeting central obesity, and consider that antiretroviral therapy interactions with frailty interventions are unstudied.

Pregnancy and Pediatrics

Frailty syndrome is not conventionally diagnosed in pregnancy or the pediatric population; however, younger adults with chronic disease (e.g., HIV, autoimmune conditions) may exhibit a frailty-like phenotype. No evidence exists for specific treatment modifications in pregnancy, exercise and nutritional optimization remain prudent. In pediatrics, the concept is limited to chronic illness with functional decline (e.g., cerebral palsy, muscular dystrophy), but no validated frailty instruments or dose adjustments are established.

End-of-Life Context

When frailty progresses to a terminal phase (e.g., recurrent hospitalization, severe disability), the focus shifts from reversal to symptom management and maintenance of comfort. Pre-stroke frailty is associated with an OR of 3.75 for longer-term mortality ^[25]B2a; among older adults with pneumonia, median survival was 62 days for those diagnosed with aspiration pneumonia vs 274 days for non-aspiration, but this difference was driven by frailty, not the aspiration label ^[5]B2b. Clinical guidance recommends using the CFS to identify patients who will not benefit from aggressive treatments (e.g., cardiac rehabilitation for arrhythmias) and instead prioritize quality of life, adequate nutrition, and advance care planning ^[31]D5.

Pearl: In the oldest-old and long-term care residents, frailty is universal, always screen with CFS and modify treatment intensity accordingly; prehabilitation is cost-effective when adherence is high ^[50]A1b.

For special populations already facing end-of-life decisions, prevention and screening may seem deferred, yet evidence demonstrates that targeted interventions across the frailty spectrum, from primary prevention to secondary prevention of progression, are feasible and effective even in the oldest old.

Primary Prevention

Preventing frailty onset requires addressing modifiable risk factors throughout midlife and early old age. Central obesity (waist circumference >102 cm in men, >88 cm in women) increases the odds of frailty by 79% versus non-frailty, and diabetes (fasting blood glucose ≥126 mg/dL) raises odds 1.84-fold ^[33]C4. Each unit increase in serum uric acid (>7 mg/dL) doubles the odds of frailty ^[33]C4. Lifestyle interventions targeting these cardiovascular risk factors, weight management , glycemic control, and exercise, are therefore foundational. Depressive symptoms independently predict adverse cognitive trajectories in frail individuals (OR 2.72 for rapid cognitive decline; fully adjusted OR 3.10), making early identification and treatment of depression a potential preventive strategy ^[45]B2b. Multicomponent physical activity programs (resistance, balance, aerobic training) improve frailty indicators in institutionalised older adults, with benefits evident even in those aged >85 years ^[85]B2a. The Otago Exercise Program significantly improves gait (WMD 0.49) and lower limb strength (WMD 0.84) in community-dwelling older adults ^[55]A1a.

Secondary Prevention (Preventing Progression)

For individuals already pre-frail or frail, intervention can reverse or slow decline. Multicomponent exercise programs lead to frailty reversal in 36% of institutionalised participants ^[85]B2a. In malnourished hospitalised patients with aging-related vulnerability (age ≥80 years, frailty, or cognitive impairment), protocol-guided individualised nutritional support reduced 30-day mortality from 13.6% to 7.1% (OR 0.48, 95%; NNT = 16) compared with routine hospital food ^[83]B2b. Benefits persisted at 180 days for mortality, functional outcomes, and quality of life ^[83]B2b. The Otago Exercise Program is particularly effective in those with compromised health, with greater improvements in gait (WMD 0.92) and lower limb strength (WMD 2.24) than in general older adults ^[55]A1a. Aggressive management of cardiovascular risk factors, especially central obesity and diabetes, may also slow frailty progression ^[33]C4.

Screening

Frailty screening is feasible in primary care following a brief skill-oriented training course; healthcare professionals reported sustained improvements in screening application at 3 months ^[58]C4. In high-risk populations, screening is essential: 85.3% of older haemodialysis patients are frail, and frailty is associated with a 3- to 5-fold higher mortality risk ^[39]B2b. Malnutrition screening using tools such as the Mini Nutritional Assessment identifies heart failure patients at risk for frailty ^[101]C4. Opportunistic screening during clinical encounters is recommended; validated instruments include the Fried Phenotype (used in ^[101]C4) and the Frailty Screening Scale ^[39]B2b. Optimal screening intervals remain undefined, but annual assessment is pragmatic in community-dwelling older adults ^[58]C4. No evidence supports universal screening in all adults; case-finding in those aged ≥70 years or with chronic illness is a reasonable approach.

Patient Education

Patients and caregivers should be educated that frailty is not an inevitable consequence of ageing, it is potentially reversible ^[85]B2a. Key messages include: (1) regular multicomponent exercise (strength, balance, and aerobic components) can improve function and reduce falls ^[55]A1a; (2) adequate protein and energy intake is critical, especially during illness ^[83]B2b; (3) managing chronic conditions (diabetes, hypertension , depression) reduces frailty risk ^{[33]C4[45]B2b}. Healthcare professional training programs can be adapted for patient-facing education ^[58]C4.

Pearl: Frailty screening is feasible in primary care after a short training course ^[58]C4.